Advertisement
U.S. markets open in 8 hours 4 minutes

Galera Therapeutics, Inc. (GRTX)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Visitors trend2W10W9M
0.0553-0.0003 (-0.45%)
At close: 01:41PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
0
0
0
0
0
-
Operating Expense
25,049
46,951
51,226
73,368
70,553
-
Operating Income
-25,049
-46,951
-51,226
-73,368
-70,553
-
Net Non Operating Interest Income Expense
-1,741
-9,819
-11,065
-7,162
-3,706
-
Other Income Expense
-2,315
-2,312
-1
-4
25
-
Pretax Income
-29,105
-59,082
-62,292
-80,534
-74,234
-
Tax Provision
-
0
-70
0
-16
-
Net Income Common Stockholders
-29,105
-59,082
-62,222
-80,534
-74,218
-
Diluted NI Available to Com Stockholders
-29,105
-59,082
-62,222
-80,534
-74,218
-
Basic EPS
-1.88
-1.33
-2.30
-3.12
-2.98
-
Diluted EPS
-1.88
-1.33
-2.30
-3.12
-2.98
-
Basic Average Shares
37,914
44,549
27,087
25,789
24,870
-
Diluted Average Shares
37,914
44,549
27,087
25,789
24,870
-
Total Operating Income as Reported
-27,358
-49,260
-51,226
-73,368
-70,553
-
Total Expenses
25,049
46,951
51,226
73,368
70,553
-
Net Income from Continuing & Discontinued Operation
-29,105
-59,082
-62,222
-80,534
-74,218
-
Normalized Income
-26,790
-56,770
-62,221
-80,530
-74,243
-
Interest Income
1,051
1,595
506
32
1,174
-
Interest Expense
2,792
11,414
11,571
7,194
4,880
-
Net Interest Income
-1,741
-9,819
-11,065
-7,162
-3,706
-
EBIT
-26,313
-47,668
-50,721
-73,340
-69,354
-
EBITDA
-26,071
-47,409
-50,607
-72,562
-68,986
-
Reconciled Depreciation
242
259
114
778
368
-
Net Income from Continuing Operation Net Minority Interest
-29,105
-59,082
-62,222
-80,534
-74,218
-
Total Unusual Items Excluding Goodwill
-2,315
-2,312
-1
-4
25
-
Total Unusual Items
-2,315
-2,312
-1
-4
25
-
Normalized EBITDA
-23,756
-45,097
-50,606
-72,558
-69,011
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
0
0
-0.001
0
0.0054
-